APA (7th ed.) Citation

Krause, M., Saalfeld, F. C., Ruge, L., Kauffmann-Guerrero, D., Illini, O., Stenzinger, A., . . . Wermke, M. (2026). Beyond EML4: Efficacy of targeted therapy in lung cancer patients with rare ALK fusions - a real-world retrospective analysis. npj precision oncology, 10(1), . https://doi.org/10.1038/s41698-026-01486-y

Chicago Style (17th ed.) Citation

Krause, Marie-Elisabeth, et al. "Beyond EML4: Efficacy of Targeted Therapy in Lung Cancer Patients with Rare ALK Fusions - a Real-world Retrospective Analysis." Npj Precision Oncology 10, no. 1 (2026). https://doi.org/10.1038/s41698-026-01486-y.

MLA (9th ed.) Citation

Krause, Marie-Elisabeth, et al. "Beyond EML4: Efficacy of Targeted Therapy in Lung Cancer Patients with Rare ALK Fusions - a Real-world Retrospective Analysis." Npj Precision Oncology, vol. 10, no. 1, 2026, https://doi.org/10.1038/s41698-026-01486-y.